Table 1: Demographic features and baseline characteristics of patient in the D + EA and D groups.

D + EA groupD group

Gender, male/total () 13/289/200.922c
Age (years, mean ± SD)62.1 ± 8.759.1 ± 12.40.334a
Duration (years, mean ± SD)2.9 ± 2.92.7 ± 2.30.719a
Tremor type () 340.628c
Rigidity-bradykinesia type ()850.784c
Mixed type ()17110.692c
H-Y Stage (stage, mean ± SD)2.0 ± 0.72.0 ± 0.80.907a
LED (mg, mean ± SD)104.1 ± 253.2160.6 ± 260.00.376a
UPSRS III (points, mean ± SD)25.6 ± 2.823.3 ± 13.00.583a
PSQI [points, median (quartile)]21.0 (18.0~25.3)16.5 (13.8~23.0)0.088b
HAMD [points, median (quartile)]12.0 (7.0~19.0)7.5 (5.0~17.8)0.098b
HAMA [points, median (quartile)]13.5 (10.0~16.0)9.0 (6.3~14.0)0.139b
MMSE [points, median (quartile)]29.0 (28.0~30.0)28.0 (25.0~29.0)0.065b
MoCA [points, median (quartile)]25.0 (22.0~28.0)23.5 (17.3~27.0)0.252b

Values are means ± standard for Student’s -test.
bValues are median (lower quartile, upper quartile) for the Kruskal-Wallis test.
cValues are discrete variables for the test.
LED: levodopa equivalent dose.